Duration of untreated psychosis and negative symptoms - A systematic review and meta-analysis of individual patient data

被引:184
作者
Boonstra, Nynke [1 ,2 ,3 ]
Klaassen, Rianne [4 ]
Sytema, Sjoerd [2 ]
Marshall, Max [5 ]
De Haan, Lieuwe [6 ]
Wunderink, Lex [1 ,2 ]
Wiersma, Durk [2 ]
机构
[1] Friesland Mental Hlth Care Serv, Dept Educ & Res, NL-8901 BS Leeuwarden, Netherlands
[2] Univ Groningen, Univ Med Ctr Groningen, Dept Psychiat, Groningen, Netherlands
[3] NHL Univ Appl Sci, Inst Healthcare & Welf Studies, Leeuwarden, Netherlands
[4] Rivierduinen, Mental Hlth Care Serv, Leiden, Netherlands
[5] Univ Manchester, Manchester, Lancs, England
[6] Univ Amsterdam, Acad Med Ctr, Dept Psychiat, NL-1105 AZ Amsterdam, Netherlands
关键词
First episode psychosis; Schizophrenia; Treatment delay; Negative symptoms; 1ST EPISODE PSYCHOSIS; 2-YEAR FOLLOW-UP; QUALITY-OF-LIFE; 1ST-EPISODE PSYCHOSIS; EARLY INTERVENTION; SCHIZOPHRENIA; ASSOCIATION; PREDICTORS; PROGRAM; INCONSISTENCY;
D O I
10.1016/j.schres.2012.08.017
中图分类号
R749 [精神病学];
学科分类号
100205 ;
摘要
Background: Longer duration of untreated psychosis (DUP) is associated with poorer outcome in terms of positive symptoms, relapse rate, and time to remission. In contrast, the association with negative symptoms is less consistent. Aims: The study had three aims. First, to arrive at a more precise estimate of the correlation between DUP and negative symptoms than previous reviews, by substantially increasing the amount of available data. Second, to see whether the strength of this correlation attenuated over longer follow-up intervals. Third, to determine whether there is a relationship between DUP and changes in negative symptoms. Method: Relevant databases were searched for studies published between December 1992 and March 2009 that reported data on DUP and negative symptoms. We obtained individual patient data where possible and calculated summary correlations between DUP and negative symptoms for each study at baseline, short and long-term follow-up. We used multilevel regression analysis to examine whether the effect of DUP on negative symptoms was the greatest in the early stages of illness. Results: We included 28 non-overlapping studies from the 402 papers detected by the search strategy. After contacting the authors we obtained individual patient data from 16 of these studies involving 3339 participants. The mean DUP was 61.4 weeks (SD = 132.7, median DUP = 12.0). Shorter DUP was significantly associated with less severe negative symptoms at baseline and also at short (1-2 years) and longer term follow-up (5-8 years) (r = 0.117, 0.180 and 0.202 respectively, p<0.001). The relationship between improvement in negative symptoms and DUP was found to be non-linear: people with a DUP shorter than 9 months showed substantially greater negative symptom reduction than those with a DUP of greater than 9 months. Conclusions: Shorter DUP is associated with less severe negative symptoms at short and long-term follow up, especially when the DUP is less than 9 months. Since there is no effective treatment for negative symptoms, reducing DUP to less than 9 months may be the best way to ameliorate them. (C) 2012 Elsevier B.V. All rights reserved.
引用
收藏
页码:12 / 19
页数:8
相关论文
共 60 条
[1]  
ADDINGTON J, 1993, J PSYCHIATR NEUROSCI, V18, P18
[2]   Duration of untreated psychosis: impact on 2-year outcome [J].
Addington, J ;
Van Mastrigt, S ;
Addington, D .
PSYCHOLOGICAL MEDICINE, 2004, 34 (02) :277-284
[3]  
Andreasen N.C., 1989, BR J PSYCHIAT S, P49
[4]  
[Anonymous], 2009, STAT STAT SOFTW REL
[5]   West London first-episode study of schizophrenia - Clinical correlates of duration of untreated psychosis [J].
Barnes, TRE ;
Hutton, SB ;
Chapman, MJ ;
Mutsatsa, S ;
Puri, BK ;
Joyce, EM .
BRITISH JOURNAL OF PSYCHIATRY, 2000, 177 :207-211
[6]  
Birchwood M, 2000, AUST NZ J PSYCHIAT, V34, pS181
[7]   Duration of untreated psychosis predicts treatment outcome in an early psychosis program [J].
Black, K ;
Peters, L ;
Rui, Q ;
Milliken, H ;
Whitehorn, D ;
Kopala, LC .
SCHIZOPHRENIA RESEARCH, 2001, 47 (2-3) :215-222
[8]   Examining the latent structure of negative symptoms: Is there a distinct subtype of negative symptom schizophrenia? [J].
Blanchard, JJ ;
Horan, WP ;
Collins, LM .
SCHIZOPHRENIA RESEARCH, 2005, 77 (2-3) :151-165
[9]  
Borenstein M., 2021, INTRO META ANAL, DOI DOI 10.1002/9780470743386
[10]   Pharmacological treatment of negative symptoms of schizophrenia: therapeutic opportunity or Cul-de-sac? [J].
Buckley, P. F. ;
Stahl, S. M. .
ACTA PSYCHIATRICA SCANDINAVICA, 2007, 115 (02) :93-100